Acquired
Novo Nordisk (Ozempic)
Ben Gilbert
So initially, the rebates worked well for drug manufacturers since there were a lot of PBMs and they could negotiate. But now that there are three big PBMs, the pharma manufacturers have essentially lost all their leverage in most cases. I'll say in most cases, and we should come back later to what are the exceptions. So rebates are extremely high.
0
💬
0
Comments
Log in to comment.
There are no comments yet.